Healthcare | September 24, 2025
Zydus, Pinkathon to drive awareness on breast cancer across India
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
The positive opinion is based on results from KOMET, the largest and only placebo-controlled, double-blind global Phase III trial in this patient population
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Agency initiates safety label change and notifies physicians of possible link
Importantly, the combination of giredestrant and everolimus was well tolerated
Clinical evidence has consistently highlighted lacosamide’s efficacy and safety.
Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
The entity will undertake the installation, operation, and maintenance of sewage treatment plants
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
Funding supports development of first-in-class pan-ROCK inhibitor ROC-101 through Phase 2a clinical testing
Subscribe To Our Newsletter & Stay Updated
